Globrands Ltd (GLRS) Fair Value & Analysis
Consumer Defensive · Il · Market cap 317M ILA
Fair value as of: Jun 25, 2026
Analysis
Globrands Ltd (GLRS) currently trades at 223.30 ILA, while our model-based Fair Value estimate is 822.19 ILA — implying the stock looks roughly 268.2% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Globrands Ltd. distributes consumer goods in Israel. The company operates through the Smoking Products Sector, Sweets and Snacks Sector, and Quality of Life Products Sector segments. It is involved in the importation, sale, and distribution of tobacco products and smoking products, including cigarettes, rolling tobacco, lighters, rolling papers, etc; distribution, sale, and marketing of sweets and snacks. In addition, the company offers over-the-counter pharmaceutical products, protein bars, medical cannabis, consumable medical equipment, and other consumer products. It serves its products to retail customers and multinational corporations under the Natural American Spirit, Camel, Winston, Kent, Pall Mall, Vogue, Rothmans, and Golden Virginia brands. The company was incorporated in 2000 and is based in Herzliya, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Globrands Ltd (GLRS) undervalued?
What is the fair value of GLRS?
What is the quality score of GLRS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.